hrp0095p1-50 | Diabetes and Insulin | ESPE2022

An Evaluation of MiniMed™ 780G System Performance in Childhood: A Single Center Experience from Turkey

Eviz Elif , Gul Yesiltepe Mutlu R. , Can Ecem , Gokce Tugba , Muradoglu Serra , Hatun Sukru

Introduction: Automated insulin delivery systems provide significant improvement in the time in range(TIR) centered diabetes care. This study analyzes the real-word performance of Minimed 780G™system-Advanced Hybrid Closed Loop(AHCL) in children from a single center.Methods: Of the 93 children started to use AHCL between January 2021 and April 2022, 64 whose data could be accessed were included. 3,6,9 and 12 month-...

hrp0097fc5.3 | Diabetes and insulin 1 | ESPE2023

How feasible is it to meet the Time in Tight Range (TITR) target with Automatic Insulin Delivery (AID)?: 2128-day real-world data from a single center

Eviz Elif , Ecem Killi Nesrin , Ege Karakus Kagan , Can Ecem , Gokce Tugba , Yesiltepe Mutlu Gul , Hatun Sukru

Introduction: With the development and use of automated insulin delivery (AID) technologies like Advanced Hybrid Closed Loop (AHCL or Minimed 780G) system, it becomes possible to achieve tighter glycemic control. A new parameter called “Time in Tight Range” (TITR, 70-140 mg/dL) has been proposed to evaluate glycemic control in the latest consensus on the use of continuous glucose monitoring (CGM) data in diabetes research. This study aims to assess...